COVID-19 is not a standard respiratory virus, it’s a serious threat to a number of vital organs. As medical specialists learn more about the virus and how it affects the human body, alarming complications are becoming evident including life-threatening blood clots in the lungs, heart and brain of COVID-19 patients.
In the Department of Cardiology, we maintain a heavy academic interest in improving the lives of our patients through careful research and scientific study.
We offer a range of diagnostic tests and treatments that are not offered anywhere else, and focus on ensuring that patients are offered the utmost in advances in recent evidence based medicine. The Alfred co-ordinates several large international research trials while also running focused tailored trials for patients, offering close clinical contact and access to cutting edge research.
We have a number of collaborative studies with Baker Heart & Diabetes Institute, the Burnet Institute and other Alfred Health departments including Gastroenterology, Rheumatology, Infectious Diseases, Cardiothoracic Surgery and Intensive Care. Several distinguished members of the department have published in the key academic journals in cardiology, from the American Heart Association, American College of Cardiology and European Society of Cardiology.
We firmly believe in patient centred care, and offering the latest that research has to offer is part of that.